An investment firm has launched its first marijuana exchange-traded fund (ETF) in Europe.

The Medical Cannabis & Wellness UCITS ETF (XETRA:CBDX) began its listing on Tuesday (January 14), and is available to investors on the Deutsche Boerse XETRA exchange based in Germany.


The new ETF has 13 holdings at this time and is overseen by a partnership between Purpose Investments and European firm HANetf, which has the backing of investor Steve Cohen’s Point72 Ventures, according to a press release.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Nawan Butt, associate portfolio manager with Purpose Investments, told the Investing News Network (INN) the European investor market has been underserved when it comes to the cannabis growth story.

“At the forefront of European cannabis investing are family offices and hedge funds, which essentially have historically been named specific investors, and what we aim to offer them is a beta exposure to the industry as a whole,” said Butt.

“Our goal is to take the wins and take the experiences from these investors and introduce European retail investors to the cannabis investment space within their regulatory frameworks.”

The Purpose Investments representative said the firm has been working with HANetf for the past year to get this ETF off the ground.

“Most European investors are limited to how they can invest in cannabis,” Butt told INN, adding that the market itself is at a very early stage, a few years behind what’s currently seen in Canada and the US.

The appetite is there for growth, but the industry will have to overcome regulatory hurdles, such as the ability to invest in recreational cannabis. Once that opens up, the European investor will have more global access.

When asked about the process for adding new stocks to the fund’s holdings, Butt said the index will employ a quarterly rebalance.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“Which means on a quarterly basis, there will be moves,” Butt said. “This is not dissimilar to what we’ve seen with the (Horizons Marijuana Life Sciences Index ETF [TSX:HMMJ]), where they’ve had large moves and index participants on a quarterly basis.”

The fund made an active decision to not include any names with ties to the recreational cannabis industry, so this discounted a lot of the Canadian corporations with significant valuations.

Butt said the fund will target the medical industry, the cannabidiol wellness segment and ancillary options. Here’s a list of the initial holdings made available through the fund:

  • Corbus Pharmaceuticals Holdings (NASDAQ:CRBP)
  • Scotts Miracle-Gro (NYSE:SMG)
  • Innovative Industrial Properties (NYSE:IIPR)
  • GW Pharmaceuticals (NASDAQ:GWPH)
  • 22nd Century Group (NYSEAMERICAN:XXII)
  • Amyris (NASDAQ:AMRS)
  • Charlotte’s Web (TSX:CWEB,OTCQX:CWBHF)
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE)
  • Pharmacielo (TSXV:PCLO,OTCQX:PCLOF)
  • Cara Therapeutics (NASDAQ:CARA)

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

(TheNewswire)

Keep reading... Show less

Market entry will address pent-up demand in the Japanese & Philippine markets for TRACE proprietary plant-based mineral formulation and wellness-focused products

Emerging leader in innovative health and wellness beverages and natural products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that has entered into an exclusive sales agency distribution agreement with Yokohama-based Mirai Marketing Inc. (“Mirai”) to bring Naturo Group’s TRACE proprietary plant-based mineral consumer products to Mirai’s extensive Japanese and Philippine sales and distribution networks.

Keep reading... Show less

Further to its press release dated April 12, 2021, Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or “ Ayurcann ”), is pleased to announce that it has oversubscribed and upsized its non-brokered private placement (the “Offering”) due to strong investor demand. The Company now anticipates that the Offering will be completed for gross proceeds of not less than $550,000.00, consisting of not less than 2,910,053 units (“Units”) at a price of $0.189 per Unit. Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one Common Share purchase warrant (a “Warrant”). Each Warrant is exercisable to acquire one Common Share at an exercise price of C$0.38 per Common Share for a period of 36 months from the date of closing of the Offering (the “Closing Date”), scheduled for April 22, 2021. The Units will have a hold period of four months and one day from the date of issuance.

Ayurcann CEO Igal Sudman commented: “We are very pleased with the demand we are seeing for the Offering. The feedback we have received to date is showing that our business is resonating with investors. We’re looking forward to closing the offering and proceeding with the planned Phase 2 build out, which will help greatly increase our facility’s capacity.”

Keep reading... Show less

UK InstaCoin APP Promises to Open NFTs up to the Masses through Social Media

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to provide an update on its recent investment in InstaCoin Technologies Ltd., a newly formed UK entity

Keep reading... Show less

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less